Showing results (1021-1030 of 12,114) with videos related to
Sort By:
Pageof 1,212
Neuropharmacology|April 28, 1999
[3H]CGP 61594, the first photoaffinity ligand for the glycine site of NMDA receptorsD Benke, M Honer, R Heckendorn, et al.Neuropharmacology|April 28, 1999
Anticonvulsant effects of eliprodil alone or combined with the glycineB receptor antagonist L-701,324 or the competitive NMDA antagonist CGP 40116 in the amygdala kindling model in ratsP Wlaź, U Ebert, W LöscherNeuropharmacology|April 28, 1999
Normal electrophysiological and behavioral responses to ethanol in mice lacking the long splice variant of the gamma2 subunit of the gamma-aminobutyrate type A receptorG E Homanics, N L Harrison, J J Quinlan, et al.Neuropharmacology|April 28, 1999
In vivo evidence against clomethiazole being neuroprotective against MDMA ('ecstasy')-induced degeneration of rat brain 5-HT nerve terminals by a free radical scavenging mechanismM I Colado, E O'Shea, B Esteban, et al.Neuropharmacology|April 28, 1999
Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTPP Calabresi, D Centonze, P Gubellini, et al.Neuropharmacology|October 25, 2000
Assessment of nicotinic acetylcholine receptor-mediated release of [(3)H]-norepinephrine from rat brain slices using a new 96-well format assayD J Anderson, P S Puttfarcken, I Jacobs, et al.Neuropharmacology|October 25, 2000
Characterization of nicotinic acetylcholine receptor-mediated [(3)H]-dopamine release from rat cortex and striatumP S Puttfarcken, I Jacobs, C R FaltynekNeuropharmacology|October 25, 2000
Cluster formation of alpha7-containing nicotinic receptors at interneuronal interfaces in cell cultureW G Conroy, L F Ogden, D K BergNeuropharmacology|October 25, 2000
Facilitation of glutamatergic neurotransmission by presynaptic nicotinic acetylcholine receptorsR Girod, N Barazangi, D McGehee, et al.Neuropharmacology|October 25, 2000
Selective neurotoxic effects of nicotine on axons in fasciculus retroflexus further support evidence that this a weak link in brain across multiple drugs of abuseJ Carlson, B Armstrong, R C Switzer, et al.Pageof 1,212